These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Sustained bromocriptine therapy in 50 previously untreated patients with Parkinson's disease. Stern GM; Lees AJ Adv Neurol; 1983; 37():17-21. PubMed ID: 6858771 [TBL] [Abstract][Full Text] [Related]
7. Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease: a 5-year follow-up. Rinne UK Neurology; 1987 May; 37(5):826-8. PubMed ID: 3574685 [TBL] [Abstract][Full Text] [Related]
8. Adjunctive therapy with bromocriptine in Parkinson's disease. Temlett JA; Ming A; Saling M; Fritz VU; Blumenfeld A; Bilchik TR; Becker AL; Fourie PB; Reef HE S Afr Med J; 1990 Dec; 78(11):680-5. PubMed ID: 2251616 [TBL] [Abstract][Full Text] [Related]
9. Bromocriptine and levodopa in early combination in Parkinson's disease: first results of the Collaborative European Multicentric Trial. Olsson JE Adv Neurol; 1990; 53():421-3. PubMed ID: 2239483 [No Abstract] [Full Text] [Related]
12. [Treatment of Parkinson's disease with bromocriptine]. Castaigne P; Laplane D; Bousser MG; Bories F Nouv Presse Med; 1976 Apr; 6(17):1482. PubMed ID: 1037400 [No Abstract] [Full Text] [Related]
13. Low-dose bromocriptine in the early phases of Parkinson's disease. Tolosa E; Blesa R; Bayes A; Forcadell F Clin Neuropharmacol; 1987 Apr; 10(2):168-74. PubMed ID: 3332610 [TBL] [Abstract][Full Text] [Related]
14. Treatment of parkinson's disease with bromocriptine. Lieberman A; Kupersmith M; Estey E; Goldstein M N Engl J Med; 1976 Dec; 295(25):1400-4. PubMed ID: 989885 [TBL] [Abstract][Full Text] [Related]
15. [Neuropsychic side effects of bromocriptine in Parkinson's disease]. Simonetta M; Schmitt L; Montastruc JL; Rascol A Rev Neurol (Paris); 1987; 143(8-9):608-11. PubMed ID: 3671965 [TBL] [Abstract][Full Text] [Related]
16. Long-term treatment of Parkinson's disease with bromocriptine. Rascol A; Guiraud B; Montastruc JL; David J; Clanet M J Neurol Neurosurg Psychiatry; 1979 Feb; 42(2):143-50. PubMed ID: 422961 [TBL] [Abstract][Full Text] [Related]
18. Early combination of dopamine agonist and levodopa in the treatment of Parkinson's disease. Rinne UK Mt Sinai J Med; 1988 Mar; 55(2):138-41. PubMed ID: 3260342 [No Abstract] [Full Text] [Related]
19. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)]. Ulm G Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619 [No Abstract] [Full Text] [Related]
20. Problems with inactivation of drugs used in Parkinson's disease. Walls TJ; Dick DJ; Fletcher J Br Med J (Clin Res Ed); 1985 Feb; 290(6466):444-5. PubMed ID: 3918623 [No Abstract] [Full Text] [Related] [Next] [New Search]